Table 14 Top 10 pairs of drugs with their correlation with subtype 2 of breast cancer, considering both combined and individually
From: Computationally repurposing drugs for breast cancer subtypes using a network-based approach
Drug1 | Drug2 | C. Cor. | Cor. 1 | Cor. 2 | C. Rank | Rank 1 | Rank 2 |
|---|---|---|---|---|---|---|---|
Goserelin-Acetate | Norethindrone | − 0.97 | − 0.80 | − 0.54 | 1 | 2 | 75 |
TG-100801 | Phensuximide | − 0.97 | − 0.57 | − 0.55 | 2 | 50 | 64 |
Goserelin-acetate | Phensuximide | − 0.96 | − 0.80 | − 0.55 | 3 | 2 | 64 |
Goserelin-acetate | Nimesulide | − 0.96 | − 0.80 | − 0.54 | 4 | 2 | 66 |
L-690330 | Favipiravir | − 0.94 | − 0.71 | − 0.53 | 5 | 7 | 83 |
Dopamine | Nimesulide | − 0.90 | − 0.57 | − 0.54 | 6 | 51 | 66 |
TG-100801 | AMG-232 | − 0.89 | − 0.57 | − 0.56 | 7 | 50 | 59 |
Tolvaptan | Zileuton | − 0.89 | − 0.67 | − 0.53 | 8 | 9 | 87 |
Emtricitabine | Finasteride | − 0.89 | − 0.60 | − 0.57 | 9 | 33 | 53 |
Nimesulide | Selamectin | − 0.89 | − 0.54 | − 0.54 | 10 | 66 | 72 |